Celyad SA Pre-Tax Profit Margin 2014-2019 | CYAD

Celyad SA pre-tax profit margin from 2014 to 2019. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Celyad SA Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.084B $0.004B
Celyad SA is a biopharmaceutical company. The Company develops and commercializes cell based regenerative therapies to treat illnesses where cardiac tissue is lost due to chronic or acute injury. Celyad SA is based in Mont-Saint-Guibert, Belgium.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.837B 13.99
Gilead Sciences (GILD) United States $83.409B 10.24
CSL (CSLLY) Australia $77.999B 0.00
Celgene (CELG) United States $74.205B 11.48
Biogen (BIIB) United States $51.990B 8.73
Vertex Pharmaceuticals (VRTX) United States $49.109B 53.07
Illumina (ILMN) United States $45.430B 53.38
Regeneron Pharmaceuticals (REGN) United States $33.093B 15.02
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.261B 11.73
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.379B 0.00
Incyte (INCY) United States $16.885B 49.69
Seattle Genetics (SGEN) United States $15.952B 0.00
Genmab (GNMSF) Denmark $13.078B 73.36
BioMarin Pharmaceutical (BMRN) United States $12.155B 0.00
Exact Sciences (EXAS) United States $11.505B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.175B 54.54
Alnylam Pharmaceuticals (ALNY) United States $9.915B 0.00
Galapagos (GLPG) Belgium $8.499B 0.00
Bio-Techne Corp (TECH) United States $7.604B 52.53
BeiGene (BGNE) Cayman Islands $6.446B 0.00
QIAGEN (QGEN) Netherlands $6.373B 20.93
Sarepta Therapeutics (SRPT) United States $6.360B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.142B 0.00
Guardant Health (GH) United States $6.101B 0.00
Amarin (AMRN) Ireland $5.826B 0.00
Reata Pharmaceuticals (RETA) United States $5.424B 0.00
Moderna (MRNA) United States $5.257B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.135B 13.05
Exelixis (EXEL) United States $5.077B 13.20
Bluebird Bio (BLUE) United States $4.848B 0.00
Medicines (MDCO) United States $4.535B 0.00
China Biologic Products (CBPO) China $4.526B 28.25
Ascendis Pharma (ASND) Denmark $4.509B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.486B 0.00
Repligen (RGEN) United States $4.073B 79.04
Spark Therapeutics (ONCE) United States $3.856B 0.00
Blueprint Medicines (BPMC) United States $3.750B 0.00
MorphoSys AG (MOR) Germany $3.633B 0.00
Immunomedics (IMMU) United States $3.089B 0.00
Mirati Therapeutics (MRTX) United States $3.027B 0.00
Alkermes (ALKS) Ireland $2.899B 0.00
Emergent Biosolutions (EBS) United States $2.800B 42.07
Genmab (GMAB) Denmark $2.744B 0.00
MyoKardia (MYOK) United States $2.598B 0.00
Genomic Health (GHDX) United States $2.511B 47.08
Arena Pharmaceuticals (ARNA) United States $2.467B 5.30
Myriad Genetics (MYGN) United States $2.402B 25.03
Ultragenyx Pharmaceutical (RARE) United States $2.393B 0.00
Acceleron Pharma (XLRN) United States $2.260B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.248B 0.00
Halozyme Therapeutics (HALO) United States $2.247B 0.00
RA PHARMCTL INC (RARX) United States $2.172B 0.00
Amicus Therapeutics (FOLD) United States $2.149B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.132B 0.00
Ligand Pharmaceuticals (LGND) United States $2.107B 26.65
NeoGenomics (NEO) United States $2.072B 110.83
Cambrex (CBM) United States $2.009B 25.40
Zai Lab (ZLAB) China $1.774B 0.00
Akcea Therapeutics (AKCA) United States $1.687B 0.00
UniQure (QURE) Netherlands $1.641B 0.00
Insmed (INSM) United States $1.625B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.583B 0.00
Denali Therapeutics (DNLI) United States $1.536B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.439B 0.00
REGENXBIO (RGNX) United States $1.413B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.401B 0.00
Coherus BioSciences (CHRS) United States $1.299B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.251B 0.00
Zymeworks (ZYME) Canada $1.199B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.110B 0.00
Innoviva (INVA) United States $1.103B 3.18
Alector (ALEC) United States $1.101B 0.00
AnaptysBio (ANAB) United States $1.012B 0.00
Editas Medicine (EDIT) United States $1.005B 0.00
Sangamo Therapeutics (SGMO) United States $0.998B 0.00
Epizyme (EPZM) United States $0.987B 0.00
Fate Therapeutics (FATE) United States $0.962B 0.00
ANI Pharmaceuticals (ANIP) United States $0.945B 15.78
Athenex (ATNX) United States $0.889B 0.00
Zealand Pharma (ZEAL) Denmark $0.865B 9.71
Achillion Pharmaceuticals (ACHN) United States $0.861B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Codexis (CDXS) United States $0.784B 0.00
Cara Therapeutics (CARA) United States $0.774B 0.00
Twist Bioscience (TWST) United States $0.772B 0.00
Anika Therapeutics (ANIK) United States $0.771B 27.30
Principia Biopharma (PRNB) United States $0.749B 387.88
WAVE Life Sciences (WVE) Singapore $0.744B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.729B 26.33
Pharming Group (PHGUF) Netherlands $0.724B 0.00
Zealand Pharma (ZLDPF) Denmark $0.722B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.705B 0.00
Vericel (VCEL) United States $0.689B 0.00
Revance Therapeutics (RVNC) United States $0.673B 0.00
Cytokineticsorporated (CYTK) United States $0.667B 0.00
Mesoblast (MESO) Australia $0.583B 0.00
Heska (HSKA) United States $0.577B 74.78
MiMedx (MDXG) United States $0.564B 0.00
Arvinas (ARVN) United States $0.552B 0.00
GENFIT S.A (GNFT) France $0.549B 0.00
Intellia Therapeutics (NTLA) United States $0.547B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.517B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.502B 0.00
Retrophin (RTRX) United States $0.492B 0.00
Intra-Cellular Therapies (ITCI) United States $0.472B 0.00
PHARMA MAR SA (PHMMF) Spain $0.468B 0.00
BioDelivery Sciences (BDSI) United States $0.466B 0.00
Adverum Biotechnologies (ADVM) United States $0.465B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.455B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.450B 0.00
Cellectis S.A (CLLS) France $0.443B 0.00
DBV Technologies S.A (DBVT) France $0.435B 0.00
Stemline Therapeutics (STML) United States $0.425B 0.00
Arcus Biosciences (RCUS) United States $0.405B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.397B 0.00
Bellus Health (BLU) Canada $0.390B 0.00
Kadmon Holdings (KDMN) United States $0.389B 0.00
Merus (MRUS) Netherlands $0.372B 0.00
AC Immune SA (ACIU) Switzerland $0.368B 27.20
Prothena (PRTA) Ireland $0.366B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.361B 0.00
Agenus (AGEN) United States $0.341B 0.00
Precision BioSciences (DTIL) United States $0.339B 0.00
CytomX Therapeutics (CTMX) United States $0.317B 0.00
Protagonist Therapeutics (PTGX) United States $0.315B 0.00
Dynavax Technologies (DVAX) United States $0.311B 0.00
Kindred Biosciences (KIN) United States $0.309B 0.00
Avid Bioservices (CDMO) United States $0.292B 0.00
Pfenex (PFNX) United States $0.291B 0.00
Starpharma Holdings (SPHRY) Australia $0.288B 0.00
Cellular Biomedicine (CBMG) United States $0.284B 0.00
ADMA Biologics Inc (ADMA) United States $0.284B 0.00
PDL BioPharma (PDLI) United States $0.283B 7.29
Theratechnologies (THTX) Canada $0.283B 0.00
Gritstone Oncology (GRTS) United States $0.281B 0.00
Geron (GERN) United States $0.281B 0.00
Scholar Rock Holding (SRRK) United States $0.279B 0.00
Puma Biotechnology (PBYI) United States $0.273B 0.00
Cel-Sci (CVM) United States $0.256B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.255B 0.00
Biofrontera AG (BFRA) Germany $0.247B 368.33
MannKind (MNKD) United States $0.247B 0.00
Syros Pharmaceuticals (SYRS) United States $0.245B 0.00
Sutro Biopharma (STRO) United States $0.239B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.231B 0.00
Seres Therapeutics (MCRB) United States $0.226B 0.00
Albireo Pharma (ALBO) United States $0.225B 0.00
Inovio Pharmaceuticals (INO) United States $0.225B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.222B 0.00
Exicure (XCUR) United States $0.214B 0.00
Kamada (KMDA) Israel $0.209B 8.00
Compugen (CGEN) Israel $0.207B 0.00
Athersys (ATHX) United States $0.206B 0.00
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
ChromaDex (CDXC) United States $0.203B 0.00
Sorrento Therapeutics (SRNE) United States $0.202B 0.00
Spero Therapeutics (SPRO) United States $0.197B 0.00
Clovis Oncology (CLVS) United States $0.188B 0.00
Palatin Technologies (PTN) United States $0.184B 5.41
Dyadic (DYAI) United States $0.180B 0.00
OSMOTICA PHARM (OSMT) United States $0.178B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.176B 0.00
Affimed (AFMD) Germany $0.175B 0.00
Prometic Life Sciences (PFSCF) Canada $0.174B 0.00
Cue Biopharma (CUE) United States $0.172B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.166B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Nicox SA (NICXF) France $0.163B 0.00
XOMA (XOMA) United States $0.161B 0.00
CorMedix Inc (CRMD) United States $0.157B 0.00
Enzo Biochem (ENZ) United States $0.154B 0.00
Arsanis (XFOR) United States $0.154B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.153B 0.00
Senesco Technologies (ELOX) United States $0.151B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.151B 0.00
BioTime (LCTX) United States $0.143B 9.58
Cerecor (CERC) United States $0.142B 0.00
Five Prime Therapeutics (FPRX) United States $0.138B 0.00
Alcobra (ARCT) United States $0.137B 0.00
Northwest Biotherapeutics (NWBO) United States $0.136B 0.00
Emmaus Life Sciences (EMMA) United States $0.126B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.124B 0.00
SESEN BIO, INC (SESN) United States $0.123B 0.00
PHASEBIO PHARMA (PHAS) United States $0.119B 0.00
Menlo Therapeutics (MNLO) United States $0.119B 0.00
Abeona Therapeutics (ABEO) United States $0.118B 0.00
Acorda Therapeutics (ACOR) United States $0.116B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.114B 0.00
NantKwest (NK) United States $0.113B 0.00
Strongbridge Biopharma (SBBP) United States $0.105B 4.29
Adaptimmune Therapeutics (ADAP) United Kingdom $0.104B 0.00
Novavax (NVAX) United States $0.104B 0.00
Aptinyx (APTX) United States $0.103B 0.00
VBI Vaccines (VBIV) United States $0.100B 0.00
Windtree Therapeutics (WINT) United States $0.098B 0.00
OvaScience (MLND) United States $0.097B 0.00
Antibe Therapeutics (ATBPF) Canada $0.093B 0.00
Trevena (TRVN) United States $0.089B 0.00
Mersana Therapeutics (MRSN) United States $0.088B 0.00
Fortress Biotech (FBIO) United States $0.087B 0.00
Adocia (ADOCY) France $0.086B 0.00
Verastem (VSTM) United States $0.084B 0.00
Liquidia Technologies (LQDA) United States $0.083B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.081B 0.00
VTv Therapeutics (VTVT) United States $0.081B 0.00
Aduro Biotech (ADRO) United States $0.080B 0.00
Vaccinex (VCNX) United States $0.077B 0.00
ARAVIVE, INC (ARAV) United States $0.077B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.077B 0.00
Idera Pharmaceuticals (IDRA) United States $0.076B 0.00
Checkpoint Therapeutics (CKPT) United States $0.075B 0.00
Prima BioMed (IMMP) Australia $0.071B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Curis (CRIS) United States $0.065B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.062B 0.00
Selecta Biosciences (SELB) United States $0.061B 0.00
Orgenesis (ORGS) United States $0.059B 21.65
NewLink Genetics (NLNK) United States $0.058B 0.00
VistaGen Therapeutics (VTGN) United States $0.058B 0.00
Pluristem Therapeutics (PSTI) Israel $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.056B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.055B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.055B 0.00
Applied Genetic Technologies (AGTC) United States $0.054B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.052B 0.00
AquaBounty Technologies (AQB) United States $0.052B 0.00
Arbutus Biopharma (ABUS) Canada $0.052B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
AIT Therapeutics (XAIR) United States $0.045B 0.00
VIVUS (VVUS) United States $0.043B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
Ophthotech (ISEE) United States $0.041B 0.00
Evogene (EVGN) Israel $0.041B 0.00
Unum Therapeutics (UMRX) United States $0.040B 0.00
Stellar Biotechnologies (EDSA) Canada $0.040B 0.00
Proteostasis Therapeutics (PTI) United States $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
Oncobiologics (OTLK) United States $0.036B 0.00
Organovo Holdings (ONVO) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Protalix BioTherapeutics (PLX) Israel $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.034B 0.00
Clearside Biomedical (CLSD) United States $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.87
BioCardia (BCDA) United States $0.028B 0.00
Entera Bio (ENTX) Israel $0.027B 0.00
Signal Genetics (MGEN) United States $0.027B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.023B 0.00
Apricus Biosciences (SEEL) United States $0.021B 0.00
Aytu Bioscience (AYTU) United States $0.021B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Soligenix (SNGX) United States $0.018B 0.00
CollPlant Holdings (CLGN) Israel $0.018B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
Pulmatrix (PULM) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Cleveland BioLabs (CBLI) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Neuralstem (CUR) United States $0.003B 0.00